A path breaking study conducted by the Peter MacCallum Cancer Centre can one day transform the way cancer is treated. The researchers have a lot of hopes from the study which was conducted on more than 1000 women. There are a lot of women that suffer from ovarian cancer each year in Australia. There have been a lot of studies in that matter in order to find substantial treatment for this type of cancer. Many health experts also adjudicate for occasional screening for women as it is very vital to detect this type of cancer at any early stage.

The study conducted by the Peter MacCallum Cancer Centre is vital and is aimed at targeting better chemotherapy. Moreover, it also tries to determine whether patients receive genetic testing. The findings that have come out of the study clearly indicate that there are some women that carry mutations BRCA1 and BRCA2 in some genes.

Due to these mutations, these women respond well to the drug as compared to other women who don't have the mutations. Moreover, these women also tend to live longer. These mutations have also been linked to the risk of breast cancer as well.